Navigation Links
QuatRx Completes Patient Enrollment in Phase 3 Study of Ophena(TM) in Women with Postmenopausal Vaginal Syndrome
Date:8/22/2007

inical development and two preclinical development programs. Fispemifene is a new, selective estrogen receptor antagonist that is in Phase 2 studies as an oral treatment for the symptoms of secondary hypogonadism in men. QRX-431, a novel, selective thyroid receptor beta agonist, is in Phase 1 studies as a potential treatment for lipid disorders and obesity. Becocalcidiol, a novel Vitamin D analogue, is in Phase 2 clinical trials for the treatment of psoriasis and was recently licensed to CollaGenex Pharmaceuticals, Inc. for continued development and commercialization. QuatRx's two preclinical small molecule programs are designed to address common endocrine disorders in women. For press releases and other Company information, please visit http://www.quatrx.com.


'/>"/>
SOURCE QuatRx Pharmaceuticals Company
Copyright©2007 PR Newswire.
All rights reserved

Page: 1 2 3

Related medicine technology :

1. Lev Pharmaceuticals Completes Phase III Prophylaxis Trial of C1-Esterase Inhibitor for Hereditary Angioedema
2. Celsion Completes Enrollment in Phase I Liver Cancer Study
3. LANI completes Phase I in Japan and to commence Phase I in UK
4. Ace Biosciences, Ace393, the Worlds First Commercial Vaccine for Travellers Diarrhoea Caused by Campylobacter Successfully Completes Phase I Clinical Trials
5. Monitoring Patient Glucose Levels: New Advances in software make it easier
6. Managing Preanalytical Processes for Patient Safety
7. Hematology Analyzers Simple, Sophisticated Technology Serving All Patients
8. Near-Patient Testing: The Advantages of C-Reactive Protein in Hematological Testing
9. Actemra (tocilizumab) Third Phase III Study Results Show Significant Improvement in Symptoms of Patients with Rheumatoid Arthritis
10. AVI BioPharma Partner Cook Medical Announces Completion of Patient Enrollment for APPRAISAL Phase II Clinical Trial for Treatment of Cardiovascular Disease
11. International ENDORSE Study Shows That the Majority of Hospitalized Patients Surveyed are at Risk for VTE and Many do not Receive Recommended VTE prophylaxis
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/27/2015)... YORK , May 27, 2015 Protein ... source, based on differences in their physical properties. The ... the largest amount of functional protein with fewest contaminants. ... to grow at a CAGR of around 5% to ... driven by increased research in the pharmaceutical and biotechnological ...
(Date:5/27/2015)... 2015  Precision Advisors ( www.precisionadvisors.com ), a Precision ... Digital Trends Study of 145 managed care executives. The ... concepts of big data and predictive analytics, but are ... The Health Information Technology for Economic and Clinical Health ... use of electronic medical records (EMRs) by 2014. While ...
(Date:5/27/2015)... , May 27, 2015 ... announced the addition of the  "US Cancer ... their offering.       (Logo: http://photos.prnewswire.com/prnh/20130307/600769) ... into to two broad categories of prophylactic ... cancer vaccines belong to both of these ...
Breaking Medicine Technology:Protein Purification & Isolation Market by Technology by Product by Application & End User - Global Forecast to 2020 2Protein Purification & Isolation Market by Technology by Product by Application & End User - Global Forecast to 2020 3Precision Advisors Digital Trends Study: Less Than Half of Managed Care Organizations Have Access to Electronic Medical Records Data 2Precision Advisors Digital Trends Study: Less Than Half of Managed Care Organizations Have Access to Electronic Medical Records Data 3US Cancer Vaccine Market Outlook 2020 2US Cancer Vaccine Market Outlook 2020 3
... Corporation (NYSE: BSX ) announces that ... Stent System demonstrated non-inferior results in treating ... year compared to the PROMUS Element™ Everolimus-Eluting Platinum ... Use Trial.  The trial reported one-year clinical and ...
... May 15, 2012  InfuSystem Holdings, Inc. (NYSE MKT:  INFU), ... services for the healthcare industry, today announced that it ... Monday, May 21, 2012 following the market close.  ... call on Tuesday, May 22, 2012 at 9:00 a.m. ...
Cached Medicine Technology:One-Year EVOLVE Trial Clinical Results Confirm Comparable Safety And Effectiveness Data Of The Boston Scientific SYNERGY™ Stent Versus PROMUS Element™ Platinum Chromium Stent 2One-Year EVOLVE Trial Clinical Results Confirm Comparable Safety And Effectiveness Data Of The Boston Scientific SYNERGY™ Stent Versus PROMUS Element™ Platinum Chromium Stent 3One-Year EVOLVE Trial Clinical Results Confirm Comparable Safety And Effectiveness Data Of The Boston Scientific SYNERGY™ Stent Versus PROMUS Element™ Platinum Chromium Stent 4One-Year EVOLVE Trial Clinical Results Confirm Comparable Safety And Effectiveness Data Of The Boston Scientific SYNERGY™ Stent Versus PROMUS Element™ Platinum Chromium Stent 5One-Year EVOLVE Trial Clinical Results Confirm Comparable Safety And Effectiveness Data Of The Boston Scientific SYNERGY™ Stent Versus PROMUS Element™ Platinum Chromium Stent 6
(Date:5/27/2015)... Bedford, New Hampshire (PRWEB) May 27, 2015 ... published in the April 2015 issue of the Journal ... of diet sodas and abdominal obesity, Bedford Commons ... consuming water instead of non-nutritive sweetener-flavored beverages. , ... long-term waist circumference, a comprehensive San Antonio Longitudinal Study ...
(Date:5/27/2015)... The MedSpa at Hendrick is excited to ... in Abilene, Texas: Xeomin®, Belotero Balance® and Radiesse®. , ... lines, better known as the lines between the eyebrows ... treat smoker’s lines around the mouth and marionette lines ... the appearance of smile lines or lines around the ...
(Date:5/27/2015)... (PRWEB) May 27, 2015 CompanionDx ... pharmacogenomic and somatic genomic analysis in personalized cancer therapy: ... by the American Society of Clinical Oncology (ASCO) as ... 2 in Chicago. , The molecular and clinical data ... Genome Atlas (TCGA) database. The study reports improved patient ...
(Date:5/27/2015)... Cincinnati Veterans Affairs Women’s Health Clinic in ... Foundation is proud to host the first annual Women Veterans ... 11 at the Freedom Center from 6 p.m. to 10 ... emcee. , This event honors and celebrates women tri-state ... The banquet is free to the first 150 women Veterans ...
(Date:5/27/2015)... Rolling Meadows, IL (PRWEB) May 27, 2015 ... the release of its SonarMD Platform, a ... engaging, monitoring and managing patients with chronic ... Lawrence Kosinski, MD, MBA, the application allows ... between visits through the ongoing use of ...
Breaking Medicine News(10 mins):Health News:Recent Study About the Link Between Diet Sodas and Abdominal Fat Reinforces Bedford Commons OB-GYN's Recommendation to Drink Plenty of Water 2Health News:The MedSpa at Hendrick Introduces Xeomin®, Belotero Balance® and Radiesse® Injectables 2Health News:CompanionDx® Analyzes Non-small Cell Lung Cancer Data for Personalized Cancer Therapy 2Health News:CompanionDx® Analyzes Non-small Cell Lung Cancer Data for Personalized Cancer Therapy 3Health News:Cincinnati VA Women’s Health Clinic Celebrates Women Veterans at Awards Banquet 2Health News:SonarMD™, LLC, Launches Game-Changing, IBD Population Health Management Platform 2
... years or longer before currently available blood tests will detect ... of Medicine scientists indicates. The analysis, which was restricted to ... types, will be published online Nov. 16 in Science ... as both bad and good news," said Sanjiv "Sam" Gambhir, ...
... of Orthopaedic Surgeons (AAOS) Board of Directors has recently ... on "The Treatment of Supracondylar Humerus Fractures." ... of the Trauma Program at the University of Toronto ... AAOS Work Group responsible for this CPG, said that ...
... --- In 2020, the vast majority of adults in America ... suffer from diabetes or pre-diabetic conditions, according to projections presented ... Scientific Sessions Wednesday, Nov. 16, in Orlando. The ... overall heart health by 20 percent in 2020. However, if ...
... a breathtaking technological revolution that promises remarkable new ways ... the release of dangerous nanoparticles, nanorobots or nanoelectronic devices ... review of more than 500 studies on the topic ... ACS, journal Molecular Pharmaceutics . Ruth Duncan ...
... less produce the finest foie gras that rich, buttery ... eaten as slices atop lightly toasted bread scientists are ... and Food Chemistry. Caroline Molette and colleagues explain ... gras, a traditional French dish, comes from its high fat ...
... issues facing lesbian, gay, bisexual and transgender baby boomers ... These seniors face higher rates of disability, physical and ... according to the first study on aging and health ... and led by Karen Fredriksen-Goldsen and colleagues at the ...
Cached Medicine News:Health News:New Stanford model establishes guidelines for earlier cancer detection 2Health News:New Stanford model establishes guidelines for earlier cancer detection 3Health News:New Stanford model establishes guidelines for earlier cancer detection 4Health News:AAOS issues new clinical practice guideline for treating common elbow fractures in children 2Health News:On track to getting even fatter 2Health News:On track to getting even fatter 3Health News:LGBT seniors face harder old age, national study finds 2Health News:LGBT seniors face harder old age, national study finds 3
... versatility that a second mirror adds, then you ... It features the same 1.5x magnification as the ... 60 and 64 respectively. Available in standard (flange) ... the "Flanged" model for laser use. ...
... AFX (Air Fluid eXchange) Lens ... designed for use in an ... its use as a primary ... low profile and sutureless design ...
... The 15° Prism is ... pathologies and are recommended ... (PDR, BRVO etc.) and ... can be used for ...
... 15° Prism are designed for ... recommended for tractional retinal detachments ... retinal detachment. They can be ... other midperipheral laser applications. Direct ...
Medicine Products: